{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:43:26Z","timestamp":1788972206312,"version":"build-2803163510"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-026-00783-8","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:40:07Z","timestamp":1773823207000},"page":"337-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lipoprotein(a) in Essential Hypertension: Associations with Blood Pressure and Hypertension-Mediated Organ Damage"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6861-6870","authenticated-orcid":false,"given":"Giulia","family":"Nardoianni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4921","authenticated-orcid":false,"given":"Giuliano","family":"Tocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7359-4028","authenticated-orcid":false,"given":"Barbara","family":"Pala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Marco","family":"Dutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7853-0042","authenticated-orcid":false,"given":"Federica","family":"Fogacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"Arrigo F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9642-8380","authenticated-orcid":false,"given":"Massimo","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0050-5178","authenticated-orcid":false,"given":"Emanuele","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"25","key":"783_CR1","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"collaboration SwgaECr","year":"2021","unstructured":"collaboration SwgaECr. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354.","journal-title":"Eur Heart J"},{"issue":"8","key":"783_CR2","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/eurheartj\/ehae609","volume":"46","author":"SHJ Hageman","year":"2025","unstructured":"Hageman SHJ, Huang Z, Lee H, Kaptoge S, Dorresteijn JAN, Pennells L, et al. Risk prediction of cardiovascular disease in the Asia-Pacific region: the SCORE2 Asia-Pacific model. Eur Heart J. 2025;46(8):702\u201315.","journal-title":"Eur Heart J"},{"issue":"9","key":"783_CR3","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1161\/HYPERTENSIONAHA.124.22998","volume":"81","author":"P Muntner","year":"2024","unstructured":"Muntner P, Jaeger BC, Foti K, Ghazi L, Bundy JD, Chen L, et al. Predicted Cardiovascular Risk by the PREVENT Equations in US Adults With Stage 1 Hypertension. Hypertension. 2024;81(9):1976\u201385.","journal-title":"Hypertension"},{"issue":"47","key":"783_CR4","doi-asserted-by":"publisher","first-page":"4791","DOI":"10.1093\/eurheartj\/ehab551","volume":"42","author":"HN Ginsberg","year":"2021","unstructured":"Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. Eur Heart J. 2021;42(47):4791\u2013806.","journal-title":"Eur Heart J"},{"key":"783_CR5","doi-asserted-by":"crossref","unstructured":"Bian X, Wang HY, Guo Y, Gao Y, An T, Dong Q et al. Residual atherosclerotic risk in older patients with atherosclerotic cardiovascular disease: where inflammation meets lipoprotein(a). Age Ageing. 2025;54(11).","DOI":"10.1093\/ageing\/afaf295"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"101008","DOI":"10.1016\/j.ajpc.2025.101008","volume":"22","author":"L Ao","year":"2025","unstructured":"Ao L, Noordam R, Jukema JW, van Heemst D, van Willems K. The interactions of Lipoprotein(a) with common cardiovascular risk factors in cardiovascular disease risk: evidence based on the UK Biobank. Am J Prev Cardiol. 2025;22:101008.","journal-title":"Am J Prev Cardiol"},{"key":"783_CR7","doi-asserted-by":"crossref","unstructured":"Arnold N, Go\u00dfling A, Bay B, Weimann J, Blaum C, Brunner FJ et al. Lipoprotein (a) and Incident Coronary Heart Disease in the Community: Impact of Traditional Cardiovascular Risk Factors. Eur J Prev Cardiol. 2025.","DOI":"10.1016\/j.atherosclerosis.2025.120358"},{"key":"783_CR8","doi-asserted-by":"crossref","unstructured":"Fogacci F, Di Micoli V, Avagimyan A, Giovannini M, Imbalzano E, Cicero AFG. Assessment of Apolipoprotein(a) Isoform Size Using Phenotypic and Genotypic Methods. Int J Mol Sci. 2023;24(18).","DOI":"10.3390\/ijms241813886"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.athplu.2024.09.004","volume":"58","author":"I Fichtner","year":"2024","unstructured":"Fichtner I, Macchi C, Rizzuto AS, Carugo S, Corsini A, Ruscica M. Lipoprotein(a) and the atherosclerotic burden - Should we wait for clinical trial evidence before taking action? Atheroscler Plus. 2024;58:16\u201323.","journal-title":"Atheroscler Plus"},{"issue":"3","key":"783_CR10","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2459\/JCM.0000000000001077","volume":"22","author":"A Cesaro","year":"2021","unstructured":"Cesaro A, Schiavo A, Moscarella E, Coletta S, Conte M, Gragnano F, et al. Lipoprotein(a): a genetic marker for cardiovascular disease and target for emerging therapies. J Cardiovasc Med (Hagerstown). 2021;22(3):151\u201361.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"1","key":"783_CR11","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/heartjnl-2021-320708","volume":"109","author":"SA Di Fusco","year":"2022","unstructured":"Di Fusco SA, Arca M, Scicchitano P, Alonzo A, Perone F, Gulizia MM, et al. Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target. Heart. 2022;109(1):18\u201325.","journal-title":"Heart"},{"issue":"5","key":"783_CR12","first-page":"1730","volume":"21","author":"B Sosnowska","year":"2025","unstructured":"Sosnowska B, Bytyci I, Lewek J, Bielecka-Dabrowa A, Burzy\u0144ska M, Jankowski P, et al. Determinants of lack of atherosclerosis progression in adult patients with elevated lipoprotein (a): results from the STAR-Lp(a) study. Arch Med Sci. 2025;21(5):1730\u201344.","journal-title":"Arch Med Sci"},{"issue":"3","key":"783_CR13","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.jacl.2018.02.007","volume":"12","author":"SL Verweij","year":"2018","unstructured":"Verweij SL, de Ronde MWJ, Verbeek R, Boekholdt SM, Planken RN, Stroes ESG, et al. Elevated lipoprotein(a) levels are associated with coronary artery calcium scores in asymptomatic individuals with a family history of premature atherosclerotic cardiovascular disease. J Clin Lipidol. 2018;12(3):597\u2013e6031.","journal-title":"J Clin Lipidol"},{"issue":"6","key":"783_CR14","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1016\/j.jacl.2025.09.030","volume":"19","author":"F Fogacci","year":"2025","unstructured":"Fogacci F, Libby P, Cicero AFG. Lipoprotein(a)-To test or not to test, not a dilemma but a mandate. J Clin Lipidol. 2025;19(6):1520\u20132.","journal-title":"J Clin Lipidol"},{"key":"783_CR15","doi-asserted-by":"crossref","unstructured":"McClintick DJ, Biery DW, Berman AN, Besser S, Shiyovich A, Singh A et al. Association between lipoprotein(a) and cardiovascular events in patients with peripheral artery disease: the Mass General Brigham Lp(a) registry. Eur J Prev Cardiol. 2025.","DOI":"10.1093\/eurjpc\/zwaf475"},{"issue":"9","key":"783_CR16","doi-asserted-by":"publisher","first-page":"e035353","DOI":"10.1161\/JAHA.124.035353","volume":"14","author":"G Kaur","year":"2025","unstructured":"Kaur G, Berman AN, Biery DW, Besser SA, Wu WY, Weber B, et al. Sex Differences in the Association Between Lipoprotein(a) and Cardiovascular Outcomes: The MGB Lp(a) Registry. J Am Heart Assoc. 2025;14(9):e035353.","journal-title":"J Am Heart Assoc"},{"issue":"11 Pt 1","key":"783_CR17","doi-asserted-by":"publisher","first-page":"102162","DOI":"10.1016\/j.jacadv.2025.102162","volume":"4","author":"O Mineeva","year":"2025","unstructured":"Mineeva O, Li C, Giulianini F, H\u00e4fliger S, Bubes V, Raetsch G, et al. Development and Validation of Novel Residual Risk Scores for Patients With ASCVD. JACC Adv. 2025;4(11 Pt 1):102162.","journal-title":"JACC Adv"},{"key":"783_CR18","doi-asserted-by":"crossref","unstructured":"Mach F, Koskinas KC, Roeters van Lennep JE, Tokg\u00f6zo\u011flu L, Badimon L, Baigent C et al. 2025 Focused Update of the 2019 ESC\/EAS Guidelines for the management of dyslipidaemias. Eur Heart J. 2025.","DOI":"10.1016\/j.atherosclerosis.2025.120479"},{"issue":"10","key":"783_CR19","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.numecd.2023.07.019","volume":"33","author":"G Chiesa","year":"2023","unstructured":"Chiesa G, Zenti MG, Baragetti A, Barbagallo CM, Borghi C, Colivicchi F, et al. Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA). Nutr Metab Cardiovasc Dis. 2023;33(10):1866\u201377.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"106425","DOI":"10.1016\/j.ejim.2025.07.021","volume":"139","author":"A Pirillo","year":"2025","unstructured":"Pirillo A, Catapano AL. Lipoprotein (a): A new target for pharmacological research and an option for treatment. Eur J Intern Med. 2025;139:106425.","journal-title":"Eur J Intern Med"},{"key":"783_CR21","doi-asserted-by":"crossref","unstructured":"Cicero AFG, Fogacci F, Giovannini M, Grandi E, D\u2019Addato S, Borghi C. Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting. Biomedicines. 2023;11(12).","DOI":"10.3390\/biomedicines11123289"},{"issue":"4","key":"783_CR22","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41371-018-0132-4","volume":"33","author":"I Figliuzzi","year":"2019","unstructured":"Figliuzzi I, Presta V, Miceli F, Citoni B, Coluccia R, Ceccarini G, et al. 24-Hour ambulatory blood pressure levels and control in a large cohort of adult outpatients with different classes of obesity. J Hum Hypertens. 2019;33(4):298\u2013307.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"783_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/jch.13181","volume":"20","author":"G Tocci","year":"2018","unstructured":"Tocci G, Presta V, Figliuzzi I, Attalla El Halabieh N, Battistoni A, Coluccia R, et al. Prevalence and clinical outcomes of white-coat and masked hypertension: Analysis of a large ambulatory blood pressure database. J Clin Hypertens (Greenwich). 2018;20(2):297\u2013305.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"783_CR24","doi-asserted-by":"crossref","unstructured":"Citoni B, Figliuzzi I, Presta V, Cesario V, Miceli F, Bianchi F et al. Prevalence and clinical characteristics of isolated systolic hypertension in young: analysis of 24\u00a0h ambulatory blood pressure monitoring database. J Hum Hypertens. 2021.","DOI":"10.1038\/s41371-021-00493-9"},{"issue":"9596","key":"783_CR25","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","volume":"370","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453\u20137.","journal-title":"Lancet"},{"issue":"4","key":"783_CR26","doi-asserted-by":"publisher","first-page":"283","DOI":"10.2165\/0151642-200815040-00008","volume":"15","author":"G Parati","year":"2008","unstructured":"Parati G, Omboni S, Palatini P, Rizzoni D, Bilo G, Valentini M, et al. Italian society of hypertension guidelines for conventional and automated blood pressure measurement in the office, at home and over 24 hours. High Blood Press Cardiovasc Prev. 2008;15(4):283\u2013310.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"7","key":"783_CR27","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","volume":"39","author":"GS Stergiou","year":"2021","unstructured":"Stergiou GS, Palatini P, Parati G, O\u2019Brien E, Januszewicz A, Lurbe E, et al. 2021 European Society of Hypertension practice guidelines for office and out-of-office blood pressure measurement. J Hypertens. 2021;39(7):1293\u2013302.","journal-title":"J Hypertens"},{"issue":"12","key":"783_CR28","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874\u20132071.","journal-title":"J Hypertens"},{"issue":"19","key":"783_CR29","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","volume":"285","author":"Expert Panel on Detection E","year":"2001","unstructured":"Expert Panel on Detection E. Treatment of High Blood Cholesterol in A. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486\u201397.","journal-title":"JAMA"},{"issue":"2","key":"783_CR30","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1161\/HYPERTENSIONAHA.119.13643","volume":"75","author":"A Virdis","year":"2020","unstructured":"Virdis A, Masi S, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, et al. Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years. Hypertension. 2020;75(2):302\u20138.","journal-title":"Hypertension"},{"issue":"1","key":"783_CR31","first-page":"88","volume":"28","author":"L Ryden","year":"2007","unstructured":"Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88\u2013136.","journal-title":"Eur Heart J"},{"issue":"23","key":"783_CR32","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/eurheartj\/ehn416","volume":"29","author":"F Van de Werf","year":"2008","unstructured":"Van de Werf F, Bax J, Betriu A, Blomstrom-Lundqvist C, Crea F, Falk V, et al. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 2008;29(23):2909\u201345.","journal-title":"Eur Heart J"},{"issue":"13","key":"783_CR33","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1093\/eurheartj\/ehm161","volume":"28","author":"JP Bassand","year":"2007","unstructured":"Bassand JP, Hamm CW, Ardissino D, Boersma E, Budaj A, Fernandez-Aviles F, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J. 2007;28(13):1598\u2013660.","journal-title":"Eur Heart J"},{"issue":"20","key":"783_CR34","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","volume":"28","author":"K Thygesen","year":"2007","unstructured":"Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28(20):2525\u201338.","journal-title":"Eur Heart J"},{"key":"783_CR35","doi-asserted-by":"crossref","unstructured":"Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Nutrition, Physical Activity, and Metabolism Council; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: the American Academy of Neurology affirms the value of this guideline. Stroke. 2006;37(6):1583\u2013633. Primary prevention of ischemic stroke: a guideline from the American Heart Association\/American Stroke Association Stroke Council: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group; Cardiovascular Nursing Council; Clinical Cardiology Council.","DOI":"10.1161\/01.STR.0000223048.70103.F1"},{"key":"783_CR36","doi-asserted-by":"crossref","unstructured":"Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, the American Heart Association\/American Stroke Association Stroke Council. Definition and evaluation of transient ischemic attack: a scientific statement for healthcare professionals from ; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke. 2009;40(6):2276-93.","DOI":"10.1161\/STROKEAHA.108.192218"},{"issue":"1","key":"783_CR37","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1093\/ehjcvp\/pvy032","volume":"5","author":"BH van den Born","year":"2019","unstructured":"van den Born BH, Lip GYH, Brguljan-Hitij J, Cremer A, Segura J, Morales E, et al. ESC Council on hypertension position document on the management of hypertensive emergencies. Eur Heart J Cardiovasc Pharmacother. 2019;5(1):37\u201346.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"5","key":"783_CR38","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2459\/JCM.0000000000000223","volume":"16","author":"ML Muiesan","year":"2015","unstructured":"Muiesan ML, Salvetti M, Amadoro V, di Somma S, Perlini S, Semplicini A, et al. An update on hypertensive emergencies and urgencies. J Cardiovasc Med (Hagerstown). 2015;16(5):372\u201382.","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"783_CR39","unstructured":"Polkinghorne MD, Badi I, Baragetti A, Chauhan J, Xie C, Wahome E et al. Lipoprotein(a) and Vascular Redox State in Patients With Advanced Coronary Atherosclerosis. Arterioscler Thromb Vasc Biol. 2025."},{"issue":"2","key":"783_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/eurjpc\/zwae271","volume":"32","author":"SL Clarke","year":"2025","unstructured":"Clarke SL, Huang RDL, Hilliard AT, Levin MG, Sharma D, Thomson B, et al. Genetically predicted lipoprotein(a) associates with coronary artery plaque severity independent of low-density lipoprotein cholesterol. Eur J Prev Cardiol. 2025;32(2):116\u201327.","journal-title":"Eur J Prev Cardiol"},{"key":"783_CR41","doi-asserted-by":"crossref","unstructured":"van den Bosch SE, Boer LM, Revers A, Schrauben EM, Ooij PV, Nederveen AJ et al. Association Between Lipoprotein(a) and Arterial Stiffness in Young Adults with Familial Hypercholesterolemia. J Clin Med. 2025;14(5).","DOI":"10.3390\/jcm14051611"},{"issue":"5","key":"783_CR42","doi-asserted-by":"publisher","first-page":"e14168","DOI":"10.1111\/eci.14168","volume":"54","author":"A Simistiras","year":"2024","unstructured":"Simistiras A, Georgiopoulos G, Delialis D, Mavraganis G, Oikonomou E, Maneta E, et al. Association of Lipoprotein(a) with arterial stiffness: A Mendelian randomization study. Eur J Clin Invest. 2024;54(5):e14168.","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"783_CR43","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.122.20189","volume":"80","author":"R Rikhi","year":"2023","unstructured":"Rikhi R, Bhatia HS, Schaich CL, Ashburn N, Tsai MY, Michos ED, et al. Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA. Hypertension. 2023;80(2):352\u201360.","journal-title":"Hypertension"},{"key":"783_CR44","doi-asserted-by":"crossref","unstructured":"Brosolo G, Da Porto A, Marcante S, Picci A, Capilupi F, Capilupi P et al. Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension? Int J Mol Sci. 2023;24(17).","DOI":"10.3390\/ijms241713363"},{"issue":"21","key":"783_CR45","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1001\/jama.1997.03540450045033","volume":"277","author":"LA Sechi","year":"1997","unstructured":"Sechi LA, Kronenberg F, De Carli S, Falleti E, Zingaro L, Catena C, et al. Association of serum lipoprotein(a) levels and apolipoprotein(a) size polymorphism with target-organ damage in arterial hypertension. JAMA. 1997;277(21):1689\u201395.","journal-title":"JAMA"},{"issue":"3","key":"783_CR46","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s10238-001-8026-z","volume":"1","author":"R Antonicelli","year":"2001","unstructured":"Antonicelli R, Testa R, Bonfigli AR, Sirolla C, Pieri C, Marra M, et al. Relationship between lipoprotein(a) levels, oxidative stress, and blood pressure levels in patients with essential hypertension. Clin Exp Med. 2001;1(3):145\u201350.","journal-title":"Clin Exp Med"},{"issue":"1","key":"783_CR47","doi-asserted-by":"publisher","first-page":"14433","DOI":"10.1038\/s41598-024-65231-w","volume":"14","author":"N Vazquez-Agra","year":"2024","unstructured":"Vazquez-Agra N, Cruces-Sande A, Barbosa-Gouveia S, Lopez-Paz JE, Camafort M, Casariego-Vales E, et al. Assessing the relationship between lipoprotein(a) levels and blood pressure among hypertensive patients beyond conventional measures. An observational study. Sci Rep. 2024;14(1):14433.","journal-title":"Sci Rep"},{"key":"783_CR48","doi-asserted-by":"crossref","unstructured":"Brosolo G, Da Porto A, Bulfone L, Vacca A, Bertin N, Colussi G et al. Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in Hypertension. Biomedicines. 2021;9(11).","DOI":"10.3390\/biomedicines9111510"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-026-00783-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-026-00783-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:42:53Z","timestamp":1780119773000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-026-00783-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":48,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1007\/s40292-026-00783-8","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to disclose to the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The present study was approved by the local Ethical Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}